insights_auto
Why is PRQR up 3.82%?
Dive Deeperchevron_right
PRQR:NASDAQ
ProQR Therapeutics NV
$1.63
arrow_upward
+3.82%(+0.060) 1D
$1.60
arrow_downward
-1.84% (-0.030)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.57
High
$1.63
Low
$1.56
Mkt. cap
230.03M
Avg. vol.
678.91K
Volume
676.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
Open
$1.57
High
$1.63
Low
$1.56
Mkt. cap
230.03M
Avg. vol.
678.91K
Volume
676.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
Bloomberg.com
·
1 hour ago
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
WANE 15
·
2 days ago
Wall Street finishes its record-setting week with gains
Yahoo Finance
·
5 hours ago
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Seeking Alpha
·
4 hours ago
S&P 500: The Quick And Easy Days Are Over (SP500)
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV